1. Home
  2. MMED

as of 04-28-2026 3:51pm EST

$12.96
+$0.04
+0.31%
Stocks Health Care Medical/Dental Instruments Nasdaq

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Founded: 1983 Country:
United States
United States
Employees: N/A City: NORTHRIDGE
Market Cap: 4.1B IPO Year: 2026
Target Price: $22.56 AVG Volume (30 days): 841.1K
Analyst Decision: Strong Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $12.80 - $17.86 Next Earning Date: 06-03-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 15.99% Revenue Growth (next year): 10.00%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: